Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Influenza

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 146 articles: HTML format

Single Articles

April 2024
1. ELIGULASHVILI A, Gordon M, Lee JS, Lee J, et al
   Long-term outcomes of hospitalized patients with SARS-CoV-2/COVID-19 with and without neurological involvement: 3-year follow-up assessment.
   PLoS Med. 2024;21:e1004263.
   PubMed     Abstract available
   
   
   February 2024
2. NICKEL NC, Phillips-Beck W, Enns JE, Ekuma O, et al
   COVID-19 diagnostic testing and vaccinations among First Nations in Manitoba: A nations-based retrospective cohort study using linked administrative data, 2020-2021.
   PLoS Med. 2024;21:e1004348.
   PubMed     Abstract available
   
   
   
3. MKOMA GF, Agyemang C, Benfield T, Rostila M, et al
   Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in Denmark.
   PLoS Med. 2024;21:e1004280.
   PubMed     Abstract available
   
   
   January 2024
4. GHARPURE R, Chard AN, Cabrera Escobar M, Zhou W, et al
   Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
   PLoS Med. 2024;21:e1004333.
   PubMed     Abstract available
   
   
   
5. PANAGI L, White SR, Pinto Pereira SM, Nugawela MD, et al
   Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study.
   PLoS Med. 2024;21:e1004315.
   PubMed     Abstract available
   
   
   December 2023
6. LEBLANC J, Dusserre-Telmon L, Chauvin A, Simon T, et al
   Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial.
   PLoS Med. 2023;20:e1004317.
   PubMed     Abstract available
   
   
   November 2023
7. HOGAN AB, Wu SL, Toor J, Olivera Mesa D, et al
   Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study.
   PLoS Med. 2023;20:e1004195.
   PubMed     Abstract available
   
   
   
8. CARTULIARES MB, Rosenvinge FS, Mogensen CB, Skovsted TA, et al
   Evaluation of point-of-care multiplex polymerase chain reaction in guiding antibiotic treatment of patients acutely admitted with suspected community-acquired pneumonia in Denmark: A multicentre randomised controlled trial.
   PLoS Med. 2023;20:e1004314.
   PubMed     Abstract available
   
   
   September 2023
9. WATKINSON RE, Williams R, Gillibrand S, Munford L, et al
   Evaluating socioeconomic inequalities in influenza vaccine uptake during the COVID-19 pandemic: A cohort study in Greater Manchester, England.
   PLoS Med. 2023;20:e1004289.
   PubMed     Abstract available
   
   
   
10. KUCHARSKI AJ, Chung K, Aubry M, Teiti I, et al
    Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening: An observational study.
    PLoS Med. 2023;20:e1004283.
    PubMed     Abstract available
    
    
    July 2023
11. XIONG X, Lui DTW, Chung MSH, Au ICH, et al
    Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    PLoS Med. 2023;20:e1004274.
    PubMed     Abstract available
    
    
    
12. HILLARY RF, McCartney DL, Smith HM, Bernabeu E, et al
    Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.
    PLoS Med. 2023;20:e1004247.
    PubMed     Abstract available
    
    
    
13. ANTILLON M, Li X, Willem L, Bilcke J, et al
    The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach.
    PLoS Med. 2023;20:e1004250.
    PubMed     Abstract available
    
    
    June 2023
14. STOWE J, Miller E, Andrews N, Whitaker HJ, et al
    Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    PLoS Med. 2023;20:e1004245.
    PubMed     Abstract available
    
    
    
15. SMITH DRM, Shirreff G, Temime L, Opatowski L, et al
    Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.
    PLoS Med. 2023;20:e1004240.
    PubMed     Abstract available
    
    
    
16. QIN K, Honjo K, Sherrill-Mix S, Liu W, et al
    Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
    PLoS Med. 2023;20:e1004157.
    PubMed     Abstract available
    
    
    
17. MARINCOWITZ C, Bouamra O, Coats T, Surendra Kumar D, et al
    Major trauma presentations and patient outcomes in English hospitals during the COVID-19 pandemic: An observational cohort study.
    PLoS Med. 2023;20:e1004243.
    PubMed     Abstract available
    
    
    May 2023
18. MARTINSON NA, Nonyane BAS, Genade LP, Berhanu RH, et al
    Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
    PLoS Med. 2023;20:e1004237.
    PubMed     Abstract available
    
    
    
19. BANHOLZER N, Zurcher K, Jent P, Bittel P, et al
    SARS-CoV-2 transmission with and without mask wearing or air cleaners in schools in Switzerland: A modeling study of epidemiological, environmental, and molecular data.
    PLoS Med. 2023;20:e1004226.
    PubMed     Abstract available
    
    
    April 2023
20. MORENO-AGOSTINO D, Fisher HL, Goodman A, Hatch SL, et al
    Long-term psychological distress trajectories and the COVID-19 pandemic in three British birth cohorts: A multi-cohort study.
    PLoS Med. 2023;20:e1004145.
    PubMed     Abstract available
    
    
    
21. SAXENA S, Chwa C
    Mental disorders and COVID-19 deaths: Clinical, public health, and human rights implications.
    PLoS Med. 2023;20:e1004220.
    PubMed     Abstract available
    
    
    
22. VIOLATO M, Pollard J, Lloyd A, Roope LSJ, et al
    The COVID-19 pandemic and health-related quality of life across 13 high- and low-middle-income countries: A cross-sectional analysis.
    PLoS Med. 2023;20:e1004146.
    PubMed     Abstract available
    
    
    
23. TOMLINSON M, Marlow M
    COVID-19 and mental health: Building back better or reimagining a new way forward?
    PLoS Med. 2023;20:e1004216.
    PubMed     Abstract available
    
    
    
24. AKSUNGER N, Vernot C, Littman R, Voors M, et al
    COVID-19 and mental health in 8 low- and middle-income countries: A prospective cohort study.
    PLoS Med. 2023;20:e1004081.
    PubMed     Abstract available
    
    
    
25. PINTO DA COSTA M, Stewart R
    Investigating time-dependent COVID-19 pandemic mental health data: Challenges and opportunities of using panel data analysis.
    PLoS Med. 2023;20:e1004219.
    PubMed     Abstract available
    
    
    
26. MYRAN DT, Roberts R, McArthur E, Jeyakumar N, et al
    Mental health and addiction health service use by physicians compared to non-physicians before and during the COVID-19 pandemic: A population-based cohort study in Ontario, Canada.
    PLoS Med. 2023;20:e1004187.
    PubMed     Abstract available
    
    
    
27. BU F, Steptoe A, Fancourt D
    Depressive and anxiety symptoms in adults during the COVID-19 pandemic in England: A panel data analysis over 2 years.
    PLoS Med. 2023;20:e1004144.
    PubMed     Abstract available
    
    
    
28. WITTEVEEN AB, Young SY, Cuijpers P, Ayuso-Mateos JL, et al
    COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence.
    PLoS Med. 2023;20:e1004206.
    PubMed     Abstract available
    
    
    
29. BEACH B, Steptoe A, Zaninotto P
    Depression and anxiety in people with cognitive impairment and dementia during the COVID-19 pandemic: Analysis of the English Longitudinal Study of Ageing.
    PLoS Med. 2023;20:e1004162.
    PubMed     Abstract available
    
    
    
30. PATEL V, Fancourt D, Furukawa TA, Kola L, et al
    Reimagining the journey to recovery: The COVID-19 pandemic and global mental health.
    PLoS Med. 2023;20:e1004224.
    PubMed     Abstract available
    
    
    
31. WELS J, Wielgoszewska B, Moltrecht B, Booth C, et al
    Home working and social and mental wellbeing at different stages of the COVID-19 pandemic in the UK: Evidence from 7 longitudinal population surveys.
    PLoS Med. 2023;20:e1004214.
    PubMed     Abstract available
    
    
    
32. FUNG KW, Baye F, Baik SH, Zheng Z, et al
    Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US.
    PLoS Med. 2023;20:e1004194.
    PubMed     Abstract available
    
    
    
33. ROCKERS PC, Leppanen JM, Tarullo A, Coetzee L, et al
    Evaluation of a community health worker home visit intervention to improve child development in South Africa: A cluster-randomized controlled trial.
    PLoS Med. 2023;20:e1004222.
    PubMed     Abstract available
    
    
    February 2023
34. NORDSTROM P, Ballin M, Nordstrom A
    Safety and effectiveness of monovalent COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden.
    PLoS Med. 2023;20:e1004127.
    PubMed     Abstract available
    
    
    
35. DAVISSE-PATURET C, Orri M, Legleye S, Florence AM, et al
    Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study.
    PLoS Med. 2023;20:e1004171.
    PubMed     Abstract available
    
    
    
36. GYLLENBERG D, Bastola K, Wan Mohd Yunus WMA, Mishina K, et al
    Comparison of new psychiatric diagnoses among Finnish children and adolescents before and during the COVID-19 pandemic: A nationwide register-based study.
    PLoS Med. 2023;20:e1004072.
    PubMed     Abstract available
    
    
    
37. SCHWARZINGER M, Luchini S, Teschl M, Alla F, et al
    Mental disorders, COVID-19-related life-saving measures and mortality in France: A nationwide cohort study.
    PLoS Med. 2023;20:e1004134.
    PubMed     Abstract available
    
    
    January 2023
38. TURTLE L, Thorpe M, Drake TM, Swets M, et al
    Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.
    PLoS Med. 2023;20:e1004086.
    PubMed     Abstract available
    
    
    
39. HAMILTON FW, Thomas M, Arnold D, Palmer T, et al
    Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A mendelian randomisation study.
    PLoS Med. 2023;20:e1004174.
    PubMed     Abstract available
    
    
    
40. WAN J, Cazer CL, Clarkberg ME, Henderson SG, et al
    Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study.
    PLoS Med. 2023;20:e1004153.
    PubMed     Abstract available
    
    
    
41. BOR J, Assoumou SA, Lane K, Diaz Y, et al
    Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.
    PLoS Med. 2023;20:e1004167.
    PubMed     Abstract available
    
    
    
42. CERQUEIRA-SILVA T, Shah SA, Robertson C, Sanchez M, et al
    Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study.
    PLoS Med. 2023;20:e1004156.
    PubMed     Abstract available
    
    
    December 2022
43. LIND ML, Robertson AJ, Silva J, Warner F, et al
    Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis.
    PLoS Med. 2022;19:e1004136.
    PubMed     Abstract available
    
    
    
44. HEINSOHN T, Lange B, Vanella P, Rodiah I, et al
    Infection and transmission risks of COVID-19 in schools and their contribution to population infections in Germany: A retrospective observational study using nationwide and regional health and education agency notification data.
    PLoS Med. 2022;19:e1003913.
    PubMed     Abstract available
    
    
    November 2022
45. BABOUEE FLURY B, Gusewell S, Egger T, Leal O, et al
    Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    PLoS Med. 2022;19:e1004125.
    PubMed     Abstract available
    
    
    
46. SUTHAR AB, Dye C
    Infection, immunity, and surveillance of COVID-19.
    PLoS Med. 2022;19:e1004132.
    PubMed     Abstract available
    
    
    
47. BERGERI I, Whelan MG, Ware H, Subissi L, et al
    Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    PLoS Med. 2022;19:e1004107.
    PubMed     Abstract available
    
    
    
48. ROESSLER M, Tesch F, Batram M, Jacob J, et al
    Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany.
    PLoS Med. 2022;19:e1004122.
    PubMed     Abstract available
    
    
    
49. BERTRAN M, Amin-Chowdhury Z, Davies HG, Allen H, et al
    COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.
    PLoS Med. 2022;19:e1004118.
    PubMed     Abstract available
    
    
    
50. NIELSEN KF, Moustsen-Helms IR, Schelde AB, Gram MA, et al
    Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    PLoS Med. 2022;19:e1004037.
    PubMed     Abstract available
    
    
    October 2022
51. LOWE DM, Brown LK, Chowdhury K, Davey S, et al
    Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 x 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
    PLoS Med. 2022;19:e1004120.
    PubMed     Abstract available
    
    
    
52. HENSLEY KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, et al
    Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
    PLoS Med. 2022;19:e1003979.
    PubMed     Abstract available
    
    
    September 2022
53. GRAM MA, Emborg HD, Schelde AB, Friis NU, et al
    Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    PLoS Med. 2022;19:e1003992.
    PubMed     Abstract available
    
    
    
54. FOFANA MO, Nery N Jr, Aguilar Ticona JP, de Andrade Belitardo EMM, et al
    Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.
    PLoS Med. 2022;19:e1004093.
    PubMed     Abstract available
    
    
    August 2022
55. SAARINEN S, Moustgaard H, Remes H, Sallinen R, et al
    Income differences in COVID-19 incidence and severity in Finland among people with foreign and native background: A population-based cohort study of individuals nested within households.
    PLoS Med. 2022;19:e1004038.
    PubMed     Abstract available
    
    
    
56. KIM S, Headley TY, Tozan Y
    Universal healthcare coverage and health service delivery before and during the COVID-19 pandemic: A difference-in-difference study of childhood immunization coverage from 195 countries.
    PLoS Med. 2022;19:e1004060.
    PubMed     Abstract available
    
    
    
57. AHMED T, Roberton T, Vergeer P, Hansen PM, et al
    Healthcare utilization and maternal and child mortality during the COVID-19 pandemic in 18 low- and middle-income countries: An interrupted time-series analysis with mathematical modeling of administrative data.
    PLoS Med. 2022;19:e1004070.
    PubMed     Abstract available
    
    
    
58. MODY A, Bradley C, Redkar S, Fox B, et al
    Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri.
    PLoS Med. 2022;19:e1004048.
    PubMed     Abstract available
    
    
    
59. NIJMAN RG, Honeyford K, Farrugia R, Rose K, et al
    Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study.
    PLoS Med. 2022;19:e1003974.
    PubMed     Abstract available
    
    
    July 2022
60. REZEL-POTTS E, Douiri A, Sun X, Chowienczyk PJ, et al
    Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK.
    PLoS Med. 2022;19:e1004052.
    PubMed     Abstract available
    
    
    
61. COBB NL, Collier S, Attia EF, Augusto O, et al
    Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020.
    PLoS Med. 2022;19:e1004035.
    PubMed     Abstract available
    
    
    
62. SHIBUYA K, Tan CC, Chun AY, Leung GM, et al
    Global human security in the post-COVID-19 era: The rising role of East Asia.
    PLoS Med. 2022;19:e1003939.
    PubMed     Abstract available
    
    
    
63. HERNANDEZ I, Dickson S, Tang S, Gabriel N, et al
    Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    PLoS Med. 2022;19:e1004069.
    PubMed     Abstract available
    
    
    
64. MASSARI M, Spila Alegiani S, Morciano C, Spuri M, et al
    Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    PLoS Med. 2022;19:e1004056.
    PubMed     Abstract available
    
    
    June 2022
65. TAKUVA S, Takalani A, Seocharan I, Yende-Zuma N, et al
    Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
    PLoS Med. 2022;19:e1004024.
    PubMed     Abstract available
    
    
    
66. WONG CKH, Lau KTK, Xiong X, Au ICH, et al
    Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    PLoS Med. 2022;19:e1004018.
    PubMed     Abstract available
    
    
    
67. CUIJPERS P, Heim E, Abi Ramia J, Burchert S, et al
    Effects of a WHO-guided digital health intervention for depression in Syrian refugees in Lebanon: A randomized controlled trial.
    PLoS Med. 2022;19:e1004025.
    PubMed     Abstract available
    
    
    
68. GRAIS RF, Baron E
    Addressing the impacts of COVID-19 on refugee health.
    PLoS Med. 2022;19:e1004050.
    PubMed    
    
    
    May 2022
69. MARTIN CA, Pan D, Melbourne C, Teece L, et al
    Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    PLoS Med. 2022;19:e1004015.
    PubMed     Abstract available
    
    
    
70. JIN P, Guo X, Chen W, Ma S, et al
    Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
    PLoS Med. 2022;19:e1003953.
    PubMed     Abstract available
    
    
    
71. VAN GILS MJ, Lavell A, van der Straten K, Appelman B, et al
    Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.
    PLoS Med. 2022;19:e1003991.
    PubMed     Abstract available
    
    
    
72. ALTARE C, Kostandova N, OKeeffe J, Hayek H, et al
    COVID-19 epidemiology and changes in health service utilization in Azraq and Zaatari refugee camps in Jordan: A retrospective cohort study.
    PLoS Med. 2022;19:e1003993.
    PubMed     Abstract available
    
    
    
73. ANNWEILER C, Beaudenon M, Gautier J, Gonsard J, et al
    High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
    PLoS Med. 2022;19:e1003999.
    PubMed     Abstract available
    
    
    
74. BUITRAGO-GARCIA D, Ipekci AM, Heron L, Imeri H, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003987.
    PubMed     Abstract available
    
    
    
75. MACHADO DB, Williamson E, Pescarini JM, Alves FJO, et al
    Relationship between the Bolsa Familia national cash transfer programme and suicide incidence in Brazil: A quasi-experimental study.
    PLoS Med. 2022;19:e1004000.
    PubMed     Abstract available
    
    
    
76. BRUMMER LE, Katzenschlager S, McGrath S, Schmitz S, et al
    Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors.
    PLoS Med. 2022;19:e1004011.
    PubMed     Abstract available
    
    
    April 2022
77. FOO D, Sarna M, Pereira G, Moore HC, et al
    Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study.
    PLoS Med. 2022;19:e1003963.
    PubMed     Abstract available
    
    
    
78. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Correction: Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003982.
    PubMed     Abstract available
    
    
    
79. WAINSTEIN M, MacDonald S, Fryer D, Young K, et al
    Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
    PLoS Med. 2022;19:e1003969.
    PubMed     Abstract available
    
    
    March 2022
80. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003932.
    PubMed     Abstract available
    
    
    
81. WANG C, Ong JJ, Zhao P, Weideman AM, et al
    Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
    PLoS Med. 2022;19:e1003930.
    PubMed     Abstract available
    
    
    
82. MAURIN C, He Z, Mentek M, Verhoeven P, et al
    Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study.
    PLoS Med. 2022;19:e1003922.
    PubMed     Abstract available
    
    
    
83. GIMMA A, Munday JD, Wong KLM, Coletti P, et al
    Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey: A repeated cross-sectional study.
    PLoS Med. 2022;19:e1003907.
    PubMed     Abstract available
    
    
    February 2022
84. SAAKSVUORI L, Betsch C, Nohynek H, Salo H, et al
    Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland.
    PLoS Med. 2022;19:e1003919.
    PubMed     Abstract available
    
    
    
85. 
    Vaccine equity: A fundamental imperative in the fight against COVID-19.
    PLoS Med. 2022;19:e1003948.
    PubMed    
    
    
    
86. KONTOPANTELIS E, Mamas MA, Webb RT, Castro A, et al
    Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study.
    PLoS Med. 2022;19:e1003904.
    PubMed     Abstract available
    
    
    
87. CAUSEY K, Mosser JF
    Learning from the COVID-19 pandemic to strengthen routine immunization systems.
    PLoS Med. 2022;19:e1003934.
    PubMed     Abstract available
    
    
    
88. MCQUAID F, Mulholland R, Sangpang Rai Y, Agrawal U, et al
    Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data.
    PLoS Med. 2022;19:e1003916.
    PubMed     Abstract available
    
    
    
89. KERR S, Joy M, Torabi F, Bedston S, et al
    First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales.
    PLoS Med. 2022;19:e1003927.
    PubMed     Abstract available
    
    
    January 2022
90. GENTILE I, Schiano Moriello N
    COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination.
    PLoS Med. 2022;19:e1003917.
    PubMed     Abstract available
    
    
    
91. STRONGMAN H, Carreira H, De Stavola BL, Bhaskaran K, et al
    Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink.
    PLoS Med. 2022;19:e1003870.
    PubMed     Abstract available
    
    
    
92. BHASKARAN K, Rentsch CT, Hickman G, Hulme WJ, et al
    Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
    PLoS Med. 2022;19:e1003871.
    PubMed     Abstract available
    
    
    
93. QUINN KL, Bell CM
    Pandemic health consequences: Grasping the long COVID tail.
    PLoS Med. 2022;19:e1003891.
    PubMed    
    
    
    
94. GUROL-URGANCI I, Waite L, Webster K, Jardine J, et al
    Obstetric interventions and pregnancy outcomes during the COVID-19 pandemic in England: A nationwide cohort study.
    PLoS Med. 2022;19:e1003884.
    PubMed     Abstract available
    
    
    December 2021
95. GRAM MA, Nielsen J, Schelde AB, Nielsen KF, et al
    Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    PLoS Med. 2021;18:e1003874.
    PubMed     Abstract available
    
    
    
96. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Coyle P, et al
    Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    PLoS Med. 2021;18:e1003879.
    PubMed     Abstract available
    
    
    
97. KARUNA S, Li SS, Grant S, Walsh SR, et al
    Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    PLoS Med. 2021;18:e1003868.
    PubMed     Abstract available
    
    
    
98. PETERSEN M, Schwab J, Havlir DV
    SARS-CoV-2 vaccine boosters: The time to act is now.
    PLoS Med. 2021;18:e1003882.
    PubMed     Abstract available
    
    
    
99. MURHEKAR MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, et al
    Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    PLoS Med. 2021;18:e1003877.
    PubMed     Abstract available
    
    
    
100. SENEFELD JW, Johnson PW, Kunze KL, Bloch EM, et al
     Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.
     PLoS Med. 2021;18:e1003872.
     PubMed     Abstract available
     
     
     November 2021
101. MARTIN CA, Marshall C, Patel P, Goss C, et al
     SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
     PLoS Med. 2021;18:e1003823.
     PubMed     Abstract available
     
     
     
102. BHANU C, Gopal DP, Walters K, Chaudhry UAR, et al
     Vaccination uptake amongst older adults from minority ethnic backgrounds: A systematic review.
     PLoS Med. 2021;18:e1003826.
     PubMed     Abstract available
     
     
     
103. EPELBOIN S, Labrosse J, De Mouzon J, Fauque P, et al
     Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
     PLoS Med. 2021;18:e1003857.
     PubMed     Abstract available
     
     
     
104. ABDOOL KARIM SS, Kelemu S, Baxter C
     COVID-19 in Africa: Catalyzing change for sustainable development.
     PLoS Med. 2021;18:e1003869.
     PubMed     Abstract available
     
     
     
105. SPLINTER MJ, Velek P, Ikram MK, Kieboom BCT, et al
     Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study.
     PLoS Med. 2021;18:e1003854.
     PubMed     Abstract available
     
     
     October 2021
106. STOVER J, Glaubius R, Teng Y, Kelly S, et al
     Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
     PLoS Med. 2021;18:e1003831.
     PubMed     Abstract available
     
     
     
107. PEARSON CAB, Bozzani F, Procter SR, Davies NG, et al
     COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
     PLoS Med. 2021;18:e1003815.
     PubMed     Abstract available
     
     
     
108. FORMICA N, Mallory R, Albert G, Robinson M, et al
     Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
     PLoS Med. 2021;18:e1003769.
     PubMed     Abstract available
     
     
     
109. BERGQVIST R, Ahlqvist VH, Lundberg M, Hergens MP, et al
     HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
     PLoS Med. 2021;18:e1003820.
     PubMed     Abstract available
     
     
     
110. GILBODY S, Littlewood E, McMillan D, Chew-Graham CA, et al
     Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial.
     PLoS Med. 2021;18:e1003779.
     PubMed     Abstract available
     
     
     
111. MO Y, Eyre DW, Lumley SF, Walker TM, et al
     Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
     PLoS Med. 2021;18:e1003816.
     PubMed     Abstract available
     
     
     
112. IOANNOU GN, Ferguson JM, O'Hare AM, Bohnert ASB, et al
     Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.
     PLoS Med. 2021;18:e1003807.
     PubMed     Abstract available
     
     
     
113. POLLETT S, Johansson MA, Reich NG, Brett-Major D, et al
     Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines.
     PLoS Med. 2021;18:e1003793.
     PubMed     Abstract available
     
     
     
114. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
     COVID-19 and global equity for health: The good, the bad, and the wicked.
     PLoS Med. 2021;18:e1003797.
     PubMed     Abstract available
     
     
     September 2021
115. FIGUEROA JP, Hotez PJ, Batista C, Ben Amor Y, et al
     Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
     PLoS Med. 2021;18:e1003772.
     PubMed     Abstract available
     
     
     
116. MUTHUKUMAR AV, Morrell W, Bierer BE
     Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.
     PLoS Med. 2021;18:e1003758.
     PubMed     Abstract available
     
     
     
117. ELLIOTT J, Whitaker M, Bodinier B, Eales O, et al
     Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
     PLoS Med. 2021;18:e1003777.
     PubMed     Abstract available
     
     
     
118. TAQUET M, Dercon Q, Luciano S, Geddes JR, et al
     Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
     PLoS Med. 2021;18:e1003773.
     PubMed     Abstract available
     
     
     
119. ADAM M, Johnston J, Job N, Dronavalli M, et al
     Evaluation of a community-based mobile video breastfeeding intervention in Khayelitsha, South Africa: The Philani MOVIE cluster-randomized controlled trial.
     PLoS Med. 2021;18:e1003744.
     PubMed     Abstract available
     
     
     August 2021
120. BRUMMER LE, Katzenschlager S, Gaeddert M, Erdmann C, et al
     Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.
     PLoS Med. 2021;18:e1003735.
     PubMed     Abstract available
     
     
     
121. KILMARX PH, Glass RI
     Building global health research capacity to address research imperatives following the COVID-19 pandemic.
     PLoS Med. 2021;18:e1003753.
     PubMed     Abstract available
     
     
     July 2021
122. SULIS G, Batomen B, Kotwani A, Pai M, et al
     Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
     PLoS Med. 2021;18:e1003682.
     PubMed     Abstract available
     
     
     
123. IWANAMI S, Ejima K, Kim KS, Noshita K, et al
     Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
     PLoS Med. 2021;18:e1003660.
     PubMed     Abstract available
     
     
     
124. KANDULA S, Shaman J
     Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study.
     PLoS Med. 2021;18:e1003693.
     PubMed     Abstract available
     
     
     June 2021
125. BUTLER-LAPORTE G, Nakanishi T, Mooser V, Morrison DR, et al
     Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
     PLoS Med. 2021;18:e1003605.
     PubMed     Abstract available
     
     
     
126. INZAULE SC, Ondoa P, Loembe MM, Tebeje YK, et al
     COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.
     PLoS Med. 2021;18:e1003666.
     PubMed     Abstract available
     
     
     
127. MAO W, Ogbuoji O, Watkins D, Bharali I, et al
     Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.
     PLoS Med. 2021;18:e1003675.
     PubMed     Abstract available
     
     
     May 2021
128. GOLDMAN M, Hermans C
     Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.
     PLoS Med. 2021;18:e1003648.
     PubMed     Abstract available
     
     
     
129. STOKES AC, Lundberg DJ, Elo IT, Hempstead K, et al
     COVID-19 and excess mortality in the United States: A county-level analysis.
     PLoS Med. 2021;18:e1003571.
     PubMed     Abstract available
     
     
     April 2021
130. KRISHNAN A, Dar L, Saha S, Narayan VV, et al
     Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
     PLoS Med. 2021;18:e1003609.
     PubMed     Abstract available
     
     
     
131. ABIMBOLA S, Asthana S, Montenegro C, Guinto RR, et al
     Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic.
     PLoS Med. 2021;18:e1003604.
     PubMed     Abstract available
     
     
     
132. GRANTZ KH, Lee EC, D'Agostino McGowan L, Lee KH, et al
     Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study.
     PLoS Med. 2021;18:e1003585.
     PubMed     Abstract available
     
     
     March 2021
133. LAFOND KE, Porter RM, Whaley MJ, Suizan Z, et al
     Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.
     PLoS Med. 2021;18:e1003550.
     PubMed     Abstract available
     
     
     
134. BALCELLS ME, Rojas L, Le Corre N, Martinez-Valdebenito C, et al
     Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
     PLoS Med. 2021;18:e1003415.
     PubMed     Abstract available
     
     
     
135. REID M, Abdool-Karim Q, Geng E, Goosby E, et al
     How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
     PLoS Med. 2021;18:e1003564.
     PubMed     Abstract available
     
     
     
136. LEONG A, Cole JB, Brenner LN, Meigs JB, et al
     Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
     PLoS Med. 2021;18:e1003553.
     PubMed     Abstract available
     
     
     January 2021
137. SELIGMAN B, Ferranna M, Bloom DE
     Social determinants of mortality from COVID-19: A simulation study using NHANES.
     PLoS Med. 2021;18:e1003490.
     PubMed     Abstract available
     
     
     December 2020
138. KIM MS, An MH, Kim WJ, Hwang TH, et al
     Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
     PLoS Med. 2020;17:e1003501.
     PubMed     Abstract available
     
     
     October 2020
139. MAKARONIDIS J, Mok J, Balogun N, Magee CG, et al
     Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
     PLoS Med. 2020;17:e1003358.
     PubMed     Abstract available
     
     
     
140. MCKEIGUE PM, Weir A, Bishop J, McGurnaghan SJ, et al
     Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
     PLoS Med. 2020;17:e1003374.
     PubMed     Abstract available
     
     
     
141. BASSETT MT, Chen JT, Krieger N
     Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
     PLoS Med. 2020;17:e1003402.
     PubMed     Abstract available
     
     
     
142. KOLHE NV, Fluck RJ, Selby NM, Taal MW, et al
     Acute kidney injury associated with COVID-19: A retrospective cohort study.
     PLoS Med. 2020;17:e1003406.
     PubMed     Abstract available
     
     
     September 2020
143. BUITRAGO-GARCIA D, Egli-Gany D, Counotte MJ, Hossmann S, et al
     Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
     PLoS Med. 2020;17:e1003346.
     PubMed     Abstract available
     
     
     
144. RENTSCH CT, Kidwai-Khan F, Tate JP, Park LS, et al
     Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
     PLoS Med. 2020;17:e1003379.
     PubMed     Abstract available
     
     
     
145. JUUL S, Nielsen EE, Feinberg J, Siddiqui F, et al
     Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
     PLoS Med. 2020;17:e1003293.
     PubMed     Abstract available
     
     
     
146. STOWE J, Andrews N, Gringras P, Quinnell T, et al
     Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
     PLoS Med. 2020;17:e1003225.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.